John D. Ingram, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2016 1st Ave S, Denison, IA 51442 Phone: 712-263-3388 Fax: 712-263-1777 |
Michael P Luft, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Medical Pkwy Ste A, Denison, IA 51442 Phone: 712-265-2700 Fax: 712-263-1777 |
Rose Mary Mason, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1820 Hwy 30 E, Denison, IA 51442 Phone: 712-263-6116 Fax: 712-263-6115 |
Dr. David Marc Tan Creti, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1820 Hwy 30 E, Denison, IA 51442 Phone: 712-263-6116 Fax: 712-263-6115 |
Patrick Luft, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Medical Pkwy, Denison, IA 51442 Phone: 712-265-2500 |
Alisha E Mor, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Medical Pkwy, Ste A, Denison, IA 51442 Phone: 712-265-2561 |
John Lothrop Iii, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Medical Pkwy Ste A, Denison, IA 51442 Phone: 712-265-2700 |
News Archive
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., announced EDARBYCLOR (azilsartan medoxomil and chlorthalidone) is now available by prescription in U.S. pharmacies for the treatment of hypertension to lower blood pressure in adults.
An unusual collaboration between cell and developmental biologists and physicists at UNC-Chapel Hill is providing insights into the relationship between the physical properties of cells and the signals that influence cell behavior.
A study comparing DNA and RNA data from Nigerian breast cancer patients to patients in a United States database found that certain aggressive molecular features were far more prevalent in tumors from Nigerian women than in black or white American women.
A new tool for neuroscientists delivers a thousand pinpricks of light to a chunk of gray matter smaller than a sugar cube. The new fiber-optic device, created by biologists and engineers at the Massachusetts Institute of Technology (MIT) in Cambridge, is the first tool that can deliver precise points of light to a 3-D section of living brain tissue. The work is a step forward for a relatively new but promising technique that uses gene therapy to turn individual brain cells on and off with light.
Patients with dementia who had signs and risk factors of a pulmonary embolism, or a blood clot in the lungs, were much less likely to be tested for pulmonary embolism than patients without dementia who had the same signs and risk factors.
› Verified 5 days ago